Loss of teeth due to accident, extraction or localized periodontal disease
Conditions
Interventions
This is a longitudinal and prospective randomized clinical study. Experimental groups: G1A: 50 areas (patients) for maxillary sinus lift with 200-500 µm granulation
G1B: 50 areas (patients) for maxillary sinus lifting with granulation 500-1000 µm
G1C: 50 areas (patients) for sinus maxillary lifting with granulation 1000-2000 µm
G2A: 50 areas (patients) to fill fresh sockets after tooth extraction with granulation 200-500 µm
G2B: 50 areas (patients) to fill fresh sockets after tooth extraction with granulation 500-1000 µm
G2C: 50 areas (patients) to fill fresh sockets after tooth extraction with granulation 1000-2000 µm
G3A: 50 areas (patients) to fill the gap between implant and alveolar bone plate after extraction and installation of immediate dental implant with granulation 200-500 µm
G3B: 50 areas (patients) to fill the gap between implant and alveolar bone plate after extraction and installation of immediate dental implant with granulation 500-1000 µm. Control groups: G1D: 50 are
G2D: 50 areas (patients) for filling fresh sockets after tooth extraction with similar material (BoneceramicR) with granulation 500-1000 µm
G3C: 50 areas (patients) to fill the gap between implant and alveolar bone plate after extraction and immediate dental implant placement with similar material (BoneceramicR) with granulation 500-1000
E06.892
Sponsors
Universidade Federal de Santa Catarina
Dentscare - LTDA
Eligibility
Age
12 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients who have indications for bone grafting in maxillary sinus lift, socket filling after tooth extraction and filling the gap after implantation immediately after tooth extraction, compatible with indications for the use of bone graft biomaterials; patients over 12 years old; both genders
Exclusion criteria
Exclusion criteria: Patients under 12 years old; patients with infected areas and acute inflammatory processes; Pregnant or breastfeeding patients; patients with endocrine diseases or uncompensated chronic diseases such as diabetes, autoimmune dysfunction, therapy; or using drugs that compromise the healing response of bone tissue como prolonged therapy with corticosteroids, chemotherapy, bisphosphonates
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The effectiveness of the biphasic ceramic will allow a tissue and clinical behavior equivalent to the control groups, when the characteristics of volume maintenance and reconstruction of the required areas are evaluated. | — |
Secondary
| Measure | Time frame |
|---|---|
| The effectiveness of biphasic ceramic in relation to tissue and clinical behavior will be equivalent in all granulations used (200-500 µm, 500-1000 µm and 1000-2000 µm). | — |
Countries
Brazil
Contacts
Public ContactRoberta Ferreira
Dentscare - LTDA
Outcome results
None listed